Vincerx Pharma, Inc. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
Vincerx Pharma, Inc. reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$5.00 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-15.
Financial Statements › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2025-05-15
- Vincerx Pharma, Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-03-31 was -$5.00M.
- Vincerx Pharma, Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2024-12-31 was -$7.99M.
- Vincerx Pharma, Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2024-09-30 was -$7.84M.
- Vincerx Pharma, Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2024-06-30 was -$1.81M.
- Vincerx Pharma, Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2024 was -$30.07M.
- Vincerx Pharma, Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2023 was -$40.16M.
- Vincerx Pharma, Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2022 was -$62.98M.
- Vincerx Pharma, Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2021 was -$39.31M, a 336.50% decline from fiscal 2020.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month as first filed | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month as first filed | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month as first filed | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 10 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | -$5.00M 10-Q · filed 2025-05-15 | -$12.99M derived: sum of 2 quarters · filed 2025-05-15 | -$20.84M derived: sum of 3 quarters · filed 2025-05-15 | -$22.64M derived: sum of 4 quarters · filed 2025-05-15 | |||||
| 2024-12-31 | -$7.99M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -$15.84M derived: sum of 2 quarters · filed 2025-03-27 | -$17.64M derived: sum of 3 quarters · filed 2025-03-27 | -$30.07M 10-K · filed 2025-03-27 | |||||
| 2024-09-30 | -$7.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$9.65M derived: sum of 2 quarters · filed 2024-11-12 | -$22.08M 10-Q · filed 2024-11-12 | -$27.03M derived: sum of 4 quarters · filed 2025-05-15 | |||||
| 2024-06-30 | -$1.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$14.24M 10-Q · filed 2024-08-08 | -$19.19M derived: sum of 3 quarters · filed 2025-05-15 | -$28.19M derived: sum of 4 quarters · filed 2025-05-15 | |||||
| 2024-03-31 | -$12.43M 10-Q · filed 2025-05-15 | -$17.38M derived: sum of 2 quarters · filed 2025-05-15 | -$26.39M derived: sum of 3 quarters · filed 2025-05-15 | -$37.94M derived: sum of 4 quarters · filed 2025-05-15 | |||||
| 2023-12-31 | -$4.95M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -$13.96M derived: sum of 2 quarters · filed 2025-03-27 | -$25.51M derived: sum of 3 quarters · filed 2025-03-27 | -$40.16M 10-K · filed 2025-03-27 | |||||
| 2023-09-30 | -$9.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$20.56M derived: sum of 2 quarters · filed 2024-11-12 | -$35.21M 10-Q · filed 2024-11-12 | -$46.47M derived: sum of 4 quarters · filed 2024-11-12 | |||||
| 2023-06-30 | -$11.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$26.20M 10-Q · filed 2024-08-08 | -$25.49M 10-Q · filed 2023-08-07 | -$37.46M derived: sum of 3 quarters · filed 2024-08-08 | -$54.34M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | -$14.65M 10-Q · filed 2024-05-14 | -$14.34M 10-Q · filed 2023-05-11 | -$25.91M derived: sum of 2 quarters · filed 2024-05-14 | -$42.79M derived: sum of 3 quarters · filed 2024-05-14 | -$61.21M derived: sum of 4 quarters · filed 2024-05-14 | ||||
| 2022-12-31 | -$11.26M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | -$28.14M derived: sum of 2 quarters · filed 2024-03-29 | -$46.56M derived: sum of 3 quarters · filed 2024-03-29 | -$62.98M 10-K · filed 2024-03-29 | -$65.37M 10-K · filed 2023-03-28 | ||||
| 2022-09-30 | -$16.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$35.30M derived: sum of 2 quarters · filed 2023-11-14 | -$51.72M 10-Q · filed 2023-11-14 | -$58.20M derived: sum of 4 quarters · filed 2023-11-14 | |||||
| 2022-06-30 | -$18.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | -$34.84M 10-Q · filed 2023-08-07 | -$41.32M derived: sum of 3 quarters · filed 2023-08-07 | -$65.84M derived: sum of 4 quarters · filed 2023-08-07 | |||||
| 2022-03-31 | -$16.42M 10-Q · filed 2023-05-11 | -$22.90M derived: sum of 2 quarters · filed 2023-05-11 | -$47.42M derived: sum of 3 quarters · filed 2023-05-11 | -$49.45M derived: sum of 4 quarters · filed 2023-05-11 | |||||
| 2021-12-31 | -$6.47M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | -$31.00M derived: sum of 2 quarters · filed 2023-03-28 | -$33.03M derived: sum of 3 quarters · filed 2023-03-28 | -$39.31M 10-K · filed 2023-03-28 | $39.31M 10-K · filed 2022-03-29 | ||||
| 2021-09-30 | -$24.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$26.56M derived: sum of 2 quarters · filed 2022-11-10 | -$32.83M 10-Q · filed 2022-11-10 | $32.83M 10-Q · filed 2021-11-12 | -$16.56M derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | -$2.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$8.31M 10-Q · filed 2022-08-11 | $8.31M 10-Q · filed 2021-08-12 | $7.97M derived: sum of 3 quarters · filed 2022-08-11 | $7.53M derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | -$6.28M 10-Q · filed 2022-05-12 | $6.28M 10-Q · filed 2021-05-17 | $10.00M derived: sum of 2 quarters · filed 2022-05-12 | $9.57M derived: sum of 3 quarters · filed 2022-05-12 | $9.60M derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $16.28M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $15.84M derived: sum of 2 quarters · filed 2022-03-29 | $15.87M derived: sum of 3 quarters · filed 2022-03-29 | $16.62M 10-K · filed 2022-03-29 | $10.72M 10-K · filed 2021-03-22 | ||||
| 2020-09-30 | -$434.30K 10-Q · filed 2020-11-10 | -$401.30K derived: sum of 2 quarters · filed 2021-08-12 | $344.00K 10-Q · filed 2021-11-12 | ||||||
| 2020-06-30 | $33.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $37.00K 10-Q · filed 2021-08-12 | -$119.54K 10-K · filed 2020-09-23 | ||||||
| 2020-03-31 | $4.00K 10-Q · filed 2021-05-17 | -$12.00K 10-Q · filed 2020-05-06 | |||||||
| 2019-12-31 | $45.00K 10-K/A · filed 2021-05-14 | ||||||||
| 2019-09-30 | -$100.00 10-Q · filed 2020-11-10 | -$100.00 derived: sum of 2 quarters · filed 2020-11-10 | -$1.55K derived: sum of 3 quarters · filed 2020-11-10 | ||||||
| 2019-06-30 | $0.00 derived: 10-K 6 month − 10-Q 3 month · filed 2020-09-23 | -$1.45K 10-K · filed 2020-09-23 | |||||||
| 2019-03-31 | -$1.45K 10-Q · filed 2020-05-06 |